Evidence Lab

Creatine Monohydrate

Creatine monohydrate is a well-studied supplement that can improve repeated high-intensity exercise and support strength gains from resistance training. Benefits vary, endurance effects are limited, and product quality and individual health context still matter.

Evidence rating: Strong

Published 7/22/2026 | Last reviewed 7/22/2026

Overview

Creatine is a naturally occurring nitrogen-containing compound made in the body and obtained in smaller amounts from foods such as meat and fish. Most body creatine is stored in skeletal muscle as free creatine and phosphocreatine. During brief, intense muscular work, phosphocreatine helps regenerate adenosine triphosphate (ATP), the immediate energy currency used for forceful contractions. Supplementation does not replace training, food, sleep or recovery; it increases the available creatine pool so the phosphagen system can better support repeated high-intensity work. The clearest evidence applies to repeated short bouts of intense activity and to adaptations from progressive resistance training. Government and sport-science guidance classify creatine monohydrate among the few supplements with substantial evidence for appropriate performance settings. Meta-analyses indicate that adding creatine to resistance training can produce greater strength gains than resistance training alone. The size of benefit varies with the exercise, training status, sex, study design, baseline diet and individual response. A recent strength meta-analysis in adults younger than 50 found overall upper- and lower-body strength benefits, while also showing that women were underrepresented and did not show a statistically significant advantage in the available sex-specific subgroup analysis. That limitation should be presented rather than assuming the same effect size for everyone. Creatine may also add a small amount to regional muscle hypertrophy when combined with resistance training. This should not be described as automatic muscle gain. The direct-imaging meta-analysis found a very small average effect, and the practical result still depends on training quality, adequate energy and protein intake, recovery, adherence and time. Creatine can also increase scale weight rapidly because water is retained within body tissues, especially during loading. Early body-mass change is therefore not equivalent to newly built contractile tissue. For repeated-sprint performance, evidence is supportive but less uniform than marketing often suggests. A meta-analysis found a possible improvement in mean power during repeated sprints, without consistent improvements in peak power or fatigue indices. This makes creatine relevant to some team-sport, sprint, lifting and repeated-effort contexts, but not a guarantee of better performance in every protocol. Evidence for steady-state endurance performance is weak; authoritative summaries describe little value for events that rely predominantly on prolonged aerobic metabolism. Added body mass can also be disadvantageous in some endurance, jumping or weight-class settings. Older adults may gain additional lean tissue and strength when creatine is combined with resistance training, but the evidence should be interpreted as support for a combined training-and-nutrition strategy, not as a replacement for progressive exercise. Evidence for cognition, mood, neurological conditions and other popular “biohacking” claims is a separate and more mixed literature. Those outcomes should not inherit the strong sports-performance rating given to repeated high-intensity work or resistance-training strength. Creatine monohydrate is the reference formulation because it is the form used in most efficacy and safety research. More expensive forms such as buffered creatine, creatine ethyl ester and other salts have not consistently demonstrated superior muscle uptake, effectiveness, stability or safety. A product may contain creatine while still differing in dose accuracy, contaminants, undeclared ingredients or manufacturing quality. Ingredient evidence must therefore remain separate from product reliability. Loading is optional. A common research loading protocol is about 20 grams per day, usually divided into four smaller servings, for five to seven days, followed by a lower daily maintenance intake. Weight-adjusted research protocols often use about 0.3 grams per kilogram per day during loading. A slower approach of roughly 3–5 grams daily can raise muscle creatine over several weeks without a loading phase. These are study protocols, not universal prescriptions. Large single servings are more likely to cause gastrointestinal discomfort, and dividing the daily amount can improve tolerability. There is no reliable evidence that taking creatine immediately before rather than immediately after training produces meaningfully different long-term strength or hypertrophy outcomes. Consistency and tolerability matter more than forcing a narrow time-of-day rule. In healthy adults, the overall safety record at commonly studied intakes is reassuring. The most predictable effects are an increase in body mass from water retention and occasional gastrointestinal symptoms, particularly with large single doses. Controlled evidence does not support the common claim that creatine itself routinely causes dehydration, heat illness or muscle cramping. Normal individual hydration planning is still required, especially during heat exposure and long training sessions. Kidney concerns need precise wording. Creatine can modestly increase serum creatinine because creatinine is a breakdown product related to creatine metabolism. Recent systematic reviews and meta-analyses have not found a significant reduction in glomerular filtration outcomes in the studied populations, but a higher serum creatinine value can complicate interpretation of creatinine-based kidney tests. This does not prove safety for every medical condition or every dose. People with known kidney disease, unexplained abnormal kidney results, significant renal risk factors or medicines that may affect kidney function should obtain clinician review rather than relying on a general healthy-adult conclusion. A clinician may consider the full clinical picture and, where appropriate, kidney markers that are less directly affected by creatine metabolism. Safety evidence is less complete in pregnancy, breastfeeding, children, adolescents and people with significant chronic disease. These groups should not be treated as extensions of healthy adult sports studies. Medical or appropriately qualified dietetic review is prudent before use. Supplements also do not undergo the same premarket approval process as medicines in the United States, and performance products can be adulterated or mislabeled. Athletes should prefer a transparent single-ingredient creatine monohydrate product with recognized independent batch testing when available. Creatine itself is not named on the World Anti-Doping Agency 2026 Prohibited List as reviewed on 22 July 2026. This is not a guarantee that a commercial product is competition-safe. Under anti-doping rules, athletes remain responsible for substances found in their bodies, and contamination or undeclared ingredients can still create a violation. The practical conclusion is therefore narrow: creatine monohydrate has strong evidence for selected high-intensity and resistance-training outcomes, but benefits are context-specific, product quality matters, and health screening cannot be replaced by a supplement article.

Common use

Evidence-supported use is mainly as an adjunct to progressive resistance training and sports or training sessions that involve repeated short, high-intensity efforts. It may be useful where additional phosphocreatine availability can support repeated force or power production. It should not be framed as necessary for general fitness, as a substitute for training or diet, or as a universal endurance aid.

Common forms

Creatine monohydrate powder or capsules are the reference forms. Micronised creatine monohydrate changes particle size and mixing characteristics but is still creatine monohydrate. Buffered creatine, creatine ethyl ester, creatine hydrochloride, creatine nitrate and other salts or blends should not be assumed superior; most outcome and safety evidence is based on monohydrate. Multi-ingredient pre-workouts must be evaluated as complete products because their safety and effect cannot be inferred from creatine alone.

Practical notes

Loading is optional. Common research approaches are either a brief divided loading phase followed by maintenance, or a lower daily intake without loading that reaches saturation more gradually. No reliable pre-versus-post workout advantage has been established, so adherence and gastrointestinal tolerance are more important than a precise clock time. Expect possible early scale-weight gain from water retention. That can be acceptable for some strength or team-sport goals but may matter in weight-category, endurance or jumping contexts. Select a single-ingredient creatine monohydrate product with a clearly stated amount per serving; athletes should seek recognized independent batch testing. Last evidence review: 22 July 2026. Version 1.0. Educational information only; this record does not prescribe an individual dose.

Claim-level evidence

Strong

Creatine monohydrate can increase strength gains when combined with resistance training.

Population: Primarily healthy adults participating in progressive resistance training; much of the literature involves younger men.

Multiple controlled trials and meta-analyses support an additional strength benefit beyond resistance training alone, particularly for upper- and lower-body maximal-strength outcomes.

Limitations: Effect sizes vary. Women are underrepresented, and a 2024 sex-specific subgroup analysis did not show a statistically significant strength advantage in women, so identical effects should not be assumed across populations.

Strong

Creatine can improve performance during repeated short, high-intensity efforts.

Population: Healthy trained and recreationally active adults performing sprinting, lifting, cycling, jumping or repeated maximal-effort work.

The phosphocreatine system directly supports rapid ATP regeneration, and numerous trials and authoritative reviews report benefits for repeated high-intensity, predominantly anaerobic work.

Limitations: Not every test or athlete responds. Benefits depend on event demands, baseline muscle creatine, training status, protocol and individual response.

Moderate

Creatine may improve mean power during repeated-sprint tests.

Population: Athletes and active adults completing repeated-sprint protocols.

A 2022 systematic review and meta-analysis reported a possible improvement in mean power across repeated sprints.

Limitations: Peak power and fatigue outcomes were not consistently improved, and protocols were heterogeneous.

Moderate

Creatine may add a small hypertrophy benefit when combined with resistance training.

Population: Adults completing structured resistance-training programmes.

Direct-imaging evidence suggests a small average advantage for regional muscle hypertrophy when creatine is added to resistance training.

Limitations: The pooled effect was very small, and early increases in body mass may partly reflect water. Training, nutrition, recovery and adherence remain the main drivers.

Moderate

Creatine combined with resistance training may support lean tissue and strength in older adults.

Population: Older adults participating in supervised or structured resistance training.

Meta-analytic evidence supports additional lean-tissue and strength gains in older adults when creatine is paired with resistance training.

Limitations: Studies vary in dose, loading strategy, training programme, health status and duration. This does not establish benefit without resistance training or replace clinical care.

Insufficient

Creatine is not a reliable general endurance-performance supplement.

Population: Endurance athletes and active adults performing predominantly prolonged aerobic exercise.

Authoritative reviews describe little value for steady-state endurance performance because these events depend less on the short-term phosphocreatine system.

Limitations: Creatine could still support strength training or repeated surges within an endurance programme, but that is different from improving continuous endurance performance.

Moderate

Claims that alternative creatine forms are superior to monohydrate are not established.

Population: Adults considering commercial creatine formulations.

Creatine monohydrate remains the reference formulation for effectiveness, uptake and safety research. Other forms have not consistently demonstrated superior outcomes.

Limitations: Absence of demonstrated superiority does not mean every form is identical; product-specific dose, purity, stability and evidence still require evaluation.

Emerging / Mixed

Cognitive and broad health claims should not receive the same strong rating as sports-performance claims.

Population: Healthy adults and clinical populations studied for cognition, mood or neurological outcomes.

Some human studies and reviews report potential cognitive benefits in selected contexts, but findings, populations, doses and outcomes are heterogeneous.

Limitations: The sports-performance evidence cannot be transferred automatically to cognition, disease treatment, mental health or general longevity claims.

Dosing context

  • Common research loading protocol - About 20 g/day in four smaller servings, or approximately 0.3 g/kg/day divided - Spread across the day rather than taken as one large serving - Usually 5–7 daysLoading raises muscle creatine more quickly but is optional. This is a research protocol, not a universal prescription.
  • Maintenance after loading - Commonly 3–5 g/day - Any consistent time that is tolerated - Used for subsequent weeks or months in many studiesIndividual needs and medical context vary. The article does not prescribe a personal dose.
  • No-loading approach - Commonly 3–5 g/day; some studies use approximately 0.03–0.1 g/kg/day - Taken consistently - Approximately 3–4 weeks to raise stores more graduallyAvoids the need for a high loading intake and may be easier to tolerate.
  • Pre- versus post-training timing - No separate dose established solely by timing - Immediately before and immediately after training have produced similar adaptations in direct comparison - Long-term consistency matters more than acute timingNo reliable timing advantage has been established. Consistency and tolerability may matter more than time of day.
  • Gastrointestinal tolerance - Use smaller divided servings rather than a large single serving when needed - May be taken with a meal if that improves tolerance - As needed during loading or maintenanceLarge single doses are more likely to cause bloating, loose stools or stomach discomfort.

Safety notes

  • Body-mass increase and water retentionEarly weight gain is common, especially with loading, and is not equivalent to the same amount of new muscle tissue. Consider the practical impact in endurance, jumping and weight-category sports.
  • Gastrointestinal discomfortBloating, nausea, loose stools or stomach discomfort are more likely with large single servings. Dividing intake can improve tolerability.
  • Serum creatinine and kidney-test interpretationCreatine can modestly raise serum creatinine without a demonstrated fall in glomerular filtration in studied populations. Tell the clinician interpreting kidney tests about creatine use.
  • Known kidney disease, unexplained abnormal renal tests or substantial renal riskHealthy-adult safety findings should not be extrapolated to kidney disease. Obtain clinician review before use and do not use this article to self-manage abnormal kidney results.
  • Pregnancy, breastfeeding, children and adolescentsRoutine sports-supplement safety evidence is incomplete in these groups. Use should be considered only with an appropriately qualified clinician or sports dietitian.
  • Dehydration, heat illness and cramping claimsControlled evidence does not show that creatine monohydrate routinely causes dehydration, heat illness or muscle cramping in healthy users. Normal hydration and heat-management practices still apply.
  • Product contamination and anti-doping exposureCreatine itself is not named on the 2026 WADA Prohibited List as reviewed on 22 July 2026, but undeclared ingredients or contamination can still cause health problems or a positive test. Batch testing reduces, but does not eliminate, risk.
  • Long-term or high-dose use outside studied populationsThe safety record is reassuring in healthy adults at commonly studied intakes, but it does not prove safety for every dose, duration, disease state or multi-ingredient combination.

Interactions

  • Creatinine-based kidney function testingCreatine use can increase serum creatinine and complicate interpretation. Inform the clinician and laboratory rather than stopping or changing treatment independently.
  • Pre-existing kidney disease or unexplained abnormal kidney resultsEvidence from healthy adults cannot be assumed to apply. Qualified medical review is required before considering supplementation.
  • Medicines or treatments that may affect kidney functionDirect creatine-drug interaction evidence is limited, but combined renal risk requires individual review by the prescribing clinician or pharmacist.
  • Multi-ingredient pre-workout or bodybuilding productsSafety and anti-doping risk depend on the complete formula, doses and product quality. Creatine evidence does not validate the other ingredients or the finished product.

References

  1. Glaister M, Rhodes L. Short-Term Creatine Supplementation and Repeated Sprint Ability—A Systematic Review and Meta-Analysis International Journal of Sport Nutrition and Exercise Metabolism. 2022.Source
  2. Operation Supplement Safety. Creatine Monohydrate: Dietary Supplement for Performance U.S. Department of Defense. 2025.Source
  3. Tsiaras A, Loufopoulos G, Theodoridis X, et al.. The effect of creatine supplementation on kidney function: a systematic review and meta-analysis of randomized controlled trials Journal of Renal Nutrition. 2026.Source
  4. Wang Z, Qiu B, Li R, Han Y, Petersen C, Liu S, Zhang Y, Liu C, Candow DG, Del Coso J. Effects of Creatine Supplementation and Resistance Training on Muscle Strength Gains in Adults <50 Years of Age: A Systematic Review and Meta-Analysis Nutrients. 2024.Source
  5. Burke R, Piñero A, Coleman M, Mohan A, Sapuppo M, Augustin F, Aragon AA, Candow DG, Forbes SC, Swinton P, Schoenfeld BJ. The Effects of Creatine Supplementation Combined with Resistance Training on Regional Measures of Muscle Hypertrophy: A Systematic Review with Meta-Analysis Nutrients. 2023.Source
  6. Forbes SC, Krentz JR, Candow DG. Timing of creatine supplementation does not influence gains in unilateral muscle hypertrophy or strength from resistance training in young adults: a within-subject design Journal of Sports Medicine and Physical Fitness. 2021.Source
  7. Australian Institute of Sport. AIS Sports Supplement Framework: Group A—Creatine (Creatine Monohydrate) Australian Sports Commission.Source
  8. World Anti-Doping Agency. The 2026 List of Prohibited Substances and Methods WADA. 2026.Source
  9. Antonio J, Candow DG, Forbes SC, Gualano B, Jagim AR, Kreider RB, Rawson ES, Smith-Ryan AE, VanDusseldorp TA, Willoughby DS, Ziegenfuss TN. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? Journal of the International Society of Sports Nutrition. 2021.Source
  10. Forbes SC, Candow DG, Ostojic SM, Roberts MD, Chilibeck PD. Meta-Analysis Examining the Importance of Creatine Ingestion Strategies on Lean Tissue Mass and Strength in Older Adults Nutrients. 2021.Source
  11. Kreider RB, Kalman DS, Antonio J, Ziegenfuss TN, Wildman R, Collins R, Candow DG, Kleiner SM, Almada AL, Lopez HL. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine Journal of the International Society of Sports Nutrition. 2017.Source
  12. Naeini EK, Eskandari M, Mortazavi M, Gholaminejad A, Karevan N. Effect of creatine supplementation on kidney function: a systematic review and meta-analysis BMC Nephrology. 2025.Source
  13. NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals National Institutes of Health.Source
  14. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements FDA. 2024.Source